A randomized prospective study of the evaluation of the clinical IVF results after following Long Antagonist protocol for controlled ovarian stimulation versus following classical antagonist protocol
A randomized prospective study of administration of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF: Single dose of Degarelix (24mg, 16mg or 12 mg), on day 24th of previous luteal face cycle, was administered. The Clinical Pregnancy and Live Birth Rates were estimated for this group of patients, comparing to the rates of the group which followed classical antagonist protocol. The number of the formed blastocysts in each group is measured, as well.
Study Type
OBSERVATIONAL
Enrollment
120
The clinical pregnancy and live birth rate according to the protocol of COS
Assisting Nature
Thessaloniki, Greece
RECRUITINGClinical Pregnancy Rate according to stimulation protocol
Clinical Pregnancy Rate according to stimulation protocol
Time frame: 6 weeks to 42 weeks after embryo transfer
Number of formed blastocysts
The number of the formed blastocysts in each group
Time frame: 5 days after the OPU day
Live Birth Rate according to stimulation protocol
Live Birth Rate according to stimulation protocol
Time frame: 6 weeks to 42 weeks after embryo transfer
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.